Reviews

Effect of estrogen and progesterone therapy on intraocular pressure: a systematic review and meta-analysis study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 18 December 2024
Published: 8 May 2025
960
Views
315
Downloads
10
HTML

Authors

This systematic review and meta-analysis aimed to assess the effect of Hormone Replacement Therapy (HRT) with estrogen and progesterone on Intraocular Pressure (IOP) in postmenopausal women, with the objective of determining whether HRT can lower IOP and potentially reduce glaucoma risk. Following PRISMA guidelines, a comprehensive search was conducted up to June 2024. Eligible studies included randomized controlled trials and observational studies that reported IOP changes in postmenopausal women undergoing HRT. The pooled mean differences in IOP were calculated using both random-effects and fixed-effect models. The meta-analysis included 9 studies with a total of 1,024 participants. The pooled analysis showed a significant reduction in IOP among women receiving HRT compared to controls, with a mean difference of 3.84 mmHg (95% CI: 2.26 to 5.41, p < 0.01) in the random-effects model, and 2.36 mmHg (95% CI: 2.08 to 2.64, p < 0.01) in the fixed-effect model. Despite these significant results, there was high heterogeneity across studies (I² = 97%), likely due to variations in hormone types, dosages, and treatment durations. HRT is associated with a significant decrease in IOP in postmenopausal women, potentially offering protective benefits against glaucoma, although further research is needed to address the observed variability.

Downloads

Download data is not yet available.

Hogan K, Cui X, Giangiacomo A, Feola AJ. Postmenopausal hormone therapy was associated with later age of onset among glaucoma cases. Invest Ophthalmol Vis Sci 2024;65:31. DOI: https://doi.org/10.1167/iovs.65.10.31

Akhavanakbari G, Entezariasl M, Ojagi H, Isazadehfar K. Comparison of the effects of remifentanil and alfentanil on intraocular pressure in cataract surgery. Saudi J Anaesth 2013;7:160-4. DOI: https://doi.org/10.4103/1658-354X.114074

Youngblood H, Schoenlein PV, Pasquale LR, et al. Estrogen dysregulation, intraocular pressure, and glaucoma risk. Exp Eye Res 2023;237:109725. DOI: https://doi.org/10.1016/j.exer.2023.109725

Xirui Y, Hui Z, Muhammad S, et al. Efficacy of bioactive compounds of Chaihu () on glaucomatous optic atrophy through interleukin-6/hypoxia inducible factor-1α signal pathway. J Tradit Chin Med 2023;43:1219-26.

Douglass A, Dattilo M, Feola AJ. Evidence for menopause as a sex-specific risk factor for glaucoma. Cell Mol Neurobiol 2023;43:79-97. DOI: https://doi.org/10.1007/s10571-021-01179-z

Viuff MH, Stochholm K, Juul S, Gravholt CH. Disorders of the eye, ear, skin, and nervous system in women with Turner syndrome -a nationwide cohort study. Eur J Hum Genet 2022;30:229-36. DOI: https://doi.org/10.1038/s41431-021-00989-5

Nuzzi R, Caselgrandi P. Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience. Int J Mol Sci 2022;23:3269. DOI: https://doi.org/10.3390/ijms23063269

Madjedi KM, Stuart KV, Chua SYL, et al. The Association of Female Reproductive Factors with Glaucoma and Related Traits: A Systematic Review. Ophthalmol Glaucoma 2022;5:628-47. DOI: https://doi.org/10.1016/j.ogla.2022.06.003

Liu K, Fan H, Hu H, et al. Genetic variation reveals the influence of steroid hormones on the risk of retinal neurodegenerative diseases. Front Endocrinol (Lausanne) 2022;13:1088557. DOI: https://doi.org/10.3389/fendo.2022.1088557

Korpole NR, Kurada P, Korpole MR. Gender difference in ocular diseases, risk factors and management with specific reference to role of sex steroid hormones. J Midlife Health 2022;13:20-5. DOI: https://doi.org/10.4103/jmh.jmh_28_22

Fotesko K, Thomsen BSV, Kolko M, Vohra R. Girl power in glaucoma: the role of estrogen in primary open angle glaucoma. Cell Mol Neurobiol 2022;42:41-57. DOI: https://doi.org/10.1007/s10571-020-00965-5

Fathy M, Noureldine A, Elmofty HM, Tolba DA. The effect of postmenopausal hormonal drop on optic nerve head and peripapillary perfusion using optical coherence tomography angiography (OCTA). Sci Rep 2022;12:18185. DOI: https://doi.org/10.1038/s41598-022-22844-3

Youngblood HA, Parker E, Cai J, et al. Identification of Estrogen Signaling in a Prioritization Study of Intraocular Pressure-Associated Genes. Int J Mol Sci 2021;22:10288. DOI: https://doi.org/10.3390/ijms221910288

Qiu Y, Yu J, Tang L, et al. Association between sex hormones and visual field progression in women with primary open angle glaucoma: a cross-sectional and prospective cohort study. Front Aging Neurosci 2021;13:756186.

Means JC, Lopez AA, Koulen P. Estrogen protects optic nerve head astrocytes against oxidative stress by preventing caspase-3 activation, tau dephosphorylation at ser(422) and the formation of tau protein aggregates. Cell Mol Neurobiol 2021;41:449-58. DOI: https://doi.org/10.1007/s10571-020-00859-6

Allen RS, Douglass A, Vo H, Feola AJ. Ovariectomy worsens visual function after mild optic nerve crush in rodents. Exp Eye Res 2021;202:108333. DOI: https://doi.org/10.1016/j.exer.2020.108333

Alambiaga-Caravaca AM, Domenech-Monsell IM, Sebastián-Morelló M, et al. Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone. Int J Pharm 2021;606:120921. DOI: https://doi.org/10.1016/j.ijpharm.2021.120921

Li S, Zhang H, Shao M, et al. Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma. Am J Ophthalmol 2020;217:55-67. DOI: https://doi.org/10.1016/j.ajo.2020.04.033

Feola AJ, Sherwood JM, Pardue MT, et al. Age and menopause effects on ocular compliance and aqueous outflow. Invest Ophthalmol Vis Sci 2020;61:16. DOI: https://doi.org/10.1167/iovs.61.5.16

Costanian C, Aubin MJ, Buhrmann R, Freeman EE. Interaction between postmenopausal hormone therapy and diabetes on cataract. Menopause 2020;27:263-8. DOI: https://doi.org/10.1097/GME.0000000000001477

Nuzzi R, Scalabrin S, Becco A, Panzica G. Sex hormones and optic nerve disorders: a review. Front Neurosci 2019;13:57. DOI: https://doi.org/10.3389/fnins.2019.00057

Lee SSY, Yazar S, Pasquale LR, et al. The relationship between optic disc parameters and female reproductive factors in young women. Asia Pac J Ophthalmol (Phila) 2019;8:224-8.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. DOI: https://doi.org/10.1136/bmj.n71

Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-8.

Affinito P, Di Spiezio Sardo A, Di Carlo C, et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003;10:482-7. DOI: https://doi.org/10.1097/01.GME.0000063568.84134.35

Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause 2003;10:53-7. DOI: https://doi.org/10.1097/00042192-200301000-00009

Altintaş O, Caglar Y, Yüksel N, et al. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004;218:120-9. DOI: https://doi.org/10.1159/000076148

Uncu G, Avci R, Uncu Y, Kaymaz C, Develioğlu O. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006;22:501-5. DOI: https://doi.org/10.1080/09513590600917919

Coksuer H, Ozcura F, Oghan F, et al. Effects of estradiol-drospirenone on ocular and nasal functions in postmenopausal women. Climacteric 2011;14:482-7. DOI: https://doi.org/10.3109/13697137.2010.539724

Özcan SC, Tolunay HE, Özcan DÖ, Adıbelli FM, Hilali NG, Kahraman K. Does HRT change intraocular pressure in postmenopausal women? Eastern J Med 2017;22:53. DOI: https://doi.org/10.5505/ejm.2017.63825

Treister G, Mannor S. Intraocular pressure and outflow facility: effect of estrogen and combined estrogen-progestin treatment in normal human eyes. Arch Ophthalmol 1970;83:311-8. DOI: https://doi.org/10.1001/archopht.1970.00990030313008

Himori N, Uchida K, Ninomiya T, et al. The relationship between equol production status and normal tension glaucoma. Internat Ophthalmol 2024;44:287. DOI: https://doi.org/10.1007/s10792-024-03225-3

Hao Y, Xiaodan J, Jiarui Y, Xuemin L. The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Menopause 2020;27:929-40. DOI: https://doi.org/10.1097/GME.0000000000001559

Feola AJ, Fu J, Allen R, et al. Menopause exacerbates visual dysfunction in experimental glaucoma. Exp Eye Res 2019;186:107706. DOI: https://doi.org/10.1016/j.exer.2019.107706

Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-5. DOI: https://doi.org/10.1016/S0378-5122(97)00091-1

Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-8. DOI: https://doi.org/10.1016/S0378-5122(97)00060-1

Rodrigo MJ, Martinez-Rincon T, Subias M, et al. Influence of sex on neuroretinal degeneration: six-month follow-up in rats with chronic glaucoma. Investigative Ophthalmol Visual Sci 2021;62:9. DOI: https://doi.org/10.1167/iovs.62.13.9

Qiu YC, Yu J, Tang L, et al. Association between sex hormones and visual field progression in women with primary open angle glaucoma: a cross-sectional and prospective cohort study. Front Aging Neurosci 2021;13:756186. DOI: https://doi.org/10.3389/fnagi.2021.756186

Zhang Q, Jan C, Guo CY, et al. Association of intraocular pressure-related factors and retinal vessel diameter with optic disc rim area in subjects with and without primary open angle glaucoma. Clin Exp Ophthalmol 2018;46:389-99. DOI: https://doi.org/10.1111/ceo.13042

Patel P, Harris A, Toris C, et al. Effects of sex hormones on ocular blood flow and intraocular pressure in primary open-angle glaucoma: a review. J Glaucoma 2018;27:1037-41. DOI: https://doi.org/10.1097/IJG.0000000000001106

How to Cite



1.
Safarpour Lima B, Sayanjali S, Shoham-Hazon N. Effect of estrogen and progesterone therapy on intraocular pressure: a systematic review and meta-analysis study. Eur J Transl Myol [Internet]. 2025 May 8 [cited 2026 May 11];35(2). Available from: https://www.pagepressjournals.org/bam/article/view/13497